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Abstract 
Purpose: Nurses have a pivotal role in bringing the benefits of genomics and precision medicine to everyday 
health care, but a concerted global effort is needed to transform nursing policy and practice to address 
widely acknowledged deficits in nurses’ genomic literacy. The purpose was to conduct a global country and 
organization review of nursing engagement with genomics, informing a landscape analysis to assess 
readiness for integration of genomics into nursing. 
Design: Global nursing leaders and nursing organizations were recruited using a purposive sampling 
strategy to complete an online survey that assessed the scope of genomic integration in practice and 
education, challenges and barriers, and priorities for action. 
Methods: The survey was administered online following an orientation webinar. Given the small numbers 
of nurse leaders globally, results were analyzed and presented descriptively. 
Findings: Delegates consisted of 23 nurse leaders from across the world. Genomic services were offered 
predominantly in specialty centers consisting mostly of newborn screening (15/18) and prenatal screening 
(11/18). Genomic literacy and infrastructure deficits were identified in both practice and education 
settings, with only one country reporting a genetic/genomic knowledge and skill requirement to practice 
as a general nurse. 
Conclusions: These data provide insights into the commitment to and capacity for nursing to integrate 
genomics, revealing common themes and challenges associated with adoption of genomic health services 
and integration into practice, education, and policy. Such insights offer valuable context and baseline 
information to guide the activities of a new Global Genomics Nursing Alliance (G2NA). The G2NA will use 
the landscaping exercise as a springboard to explore how to accelerate the integration of genomics into 
nursing healthcare. Clinical Relevance: Genomics is relevant to all healthcare providers across the 
healthcare continuum. It provides an underpinning for understanding health, risks for and manifestations 
of disease, therapeutic decisions, development of new therapies, and responses to interventions. 
Harnessing the benefits of genomics to improve health and care outcomes and reduce costs is a global 
nursing challenge. 
As the largest single healthcare professional group worldwide, nurses have a pivotal role in bringing the 
benefits of genomics to everyday health care; however, a global effort is needed to transform nursing 
policy, practice, education, and research (World Health Organization [WHO], 2016). Embracing genomic 
health care requires a prepared workforce. This represents a significant challenge, since deficits in genomic 
literacy in nursing and other health professions are widely acknowledged (Calzone, Jenkins, Culp, Caskey, 
& Badzek, 2014; Skirton, O’Connor, & Humphreys, 2012). Therefore, there is a need to assess existing 
genomic integration, as well as challenges or barriers, and to gauge readiness for a collaborative global 
effort to increase nursing capacity to integrate genomics into practice. 
Background 
Developments in genomics and its translation to improve healthcare continue unabated (Davies, 2017). 
Genomics advances have implications worldwide, across the healthcare continuum, and impact all nurses 
regardless of academic preparation, role, or clinical specialty (Umberger, Holston, Hutson, & Pierce, 2013). 
Embracing genomic health care requires a prepared workforce that can inform, educate, and empower 
people, address existing and novel ethical issues, and anticipate any potential negative impact on 
vulnerable populations (Badzek, Henaghan, Turner, & Monsen, 2013; Seven, Eroglu, Akyuz, & Ingvoldstad, 
2017; Tekola-Ayele & Rotimi, 2015). Nurses have a pivotal role in leading change to advance health, 
integrating research discoveries into ethical healthcare practice benefiting individuals and societies 
(Salmon & Maeda, 2016). However, there is substantial evidence that many nurses worldwide lack 
confidence and competence in genomics, and education provision is inconsistent (Calzone et al., 2014; 
Skirton et al., 2012). A survey of 10 countries, including the United States, United Kingdom, Israel, Brazil, 
Pakistan, and South Africa, found that genetics competence is not included within the regulatory standards 
of six countries and is explicit in only one, defined as “only at the basic level” (Kirk, Calzone, Arimori, & 
Tonkin, 2011). The conclusion was that concerted and strategic global effort is needed to prepare and 
enable nurses to drive progress, influence policy, and maximize existing resources to promote nursing 
literacy in genomics that includes associated ethical, legal, and societal challenges (Kirk et al., 2011). This 
was echoed by Williams and colleagues, who acknowledge the critical role of nursing in implementation of 
genomics (Williams, Feero, Leonard, & Coleman, 2017). Nursing policy, education, practice, and research 
in genomics needs to be strengthened worldwide, and policy initiatives in some countries, such as England, 
may inform how this could be achieved elsewhere (Health Education England [HEE], 2017). Motivated by 
the need to embrace this challenge, the authors facilitated an interactive event to harness influence and 
knowledge, with the aim of creating a Global Genomics Nursing Alliance (G2NA; https://www.g2na.org) to 
accelerate integration of genomics into everyday professional practice. This article presents the first phase 
of that wider initiative. 
Aims 
As a starting point for the establishment of the G2NA, we conducted a country- and organization-specific 
landscape analysis to assess the factors likely to impact readiness for and scope of genomic integration into 
nursing policy, practice, and education. We sought to identify the range of genomic services available, the 
healthcare contexts within which they operate, and the challenges, barriers, and areas of action for nursing. 
The aim was to provide context and insights into the commitment, capacity, and challenges around the 
integration of genomics into nursing, and to inform a framework for action for the G2NA. This project was 
reviewed and approved by the Faculty of Life Sciences and Education Ethics Committee, University of South 
Wales. 
Methods 
Recruitment 
This project utilized a purposive sampling strategy. Survey participation was limited to delegates 
attending the inaugural 2017 G2NA meeting. The number of delegates was constrained by available grant 
funding and meeting space. Country delegates were selected based on their expertise in nursing, health 
care, services, policy, and leadership within their country. Expertise in genomics was not required. Some 
delegates were not nurses but represented the nursing community in their country or provided a critical 
perspective to inform the work of the G2NA. There was an effort to have a broad geographical 
representation. We also strived to achieve a gender balance similar to the international nursing workforce, 
which is approximately 16% men (WHO, 2017a). Organizational delegates represented international 
nursing and genetic organizations: International Council of Nurses (ICN), Sigma Theta Tau International 
(STTI), International Society of Nurses in Genetics (ISONG), European Society for Human Genetics; two large 
national genomics and health organizations (U.S. National Human Genome Research Institute and HEE 
Genomics Education Programme), and a national advocacy group for individuals and families affected by 
genetic disorders (Genetic Alliance UK). Delegates were identified via international nursing networks and 
an iterative process by the authors to identify the optimal representative at the most appropriate and 
highest level (e.g., current president). 
Instrument 
The WHO describes a landscape analysis as a review of positive and negatives factors that might influence 
the likelihood of adoption of a new development, initiative, or technology (WHO, 2010). The survey 
instrument was developed specifically for this project, and questions were designed to ascertain the 
country- and organizationspecific context. Questions were adapted with permission from Manolio et al. 
(2015) and leveled for nursing by the authors, drawing on previous work assessing critical success factors 
in genetics/genomics integration in nursing (Kirk et al., 2011). The survey was pilot tested by the authors 
and other genomics and nursing experts, then revised prior to administration. Questions solicited 
information based on the delegate representation: country versus organization. Country questions sought 
information on the healthcare system, nursing, and genomics in mainstream and specialist services, as well 
as challenges and priorities in integrating genomics into nursing. Organization questions requested 
information on the scope of the organization (national or international), type and size of membership, 
existing genomic learning resources, and the organization perspective of challenges and priorities in 
integrating genomics into nursing. All delegates were asked to identify minimal needs to enable and ensure 
the integration of genomics across nursing practice, education, research, and policy, and to prioritize a list 
of nine areas for action. The nine areas for action were established through group discussion and 
anonymous voting at a plenary session at the ISONG Annual 2016 Congress. The survey was administered 
online in November 2016 following an explanatory webinar. Other demographics and indicators used to 
assess readiness and inform landscape analysis were obtained through review of routinely available data 
from the WHO and United Nations (2017). 
Analysis 
Data were exported into Excel for analysis. Results were tabulated and analyzed using descriptive 
statistics. There are very few global nurse leaders, so the sample size is necessarily small. Given the small 
sample we have chosen to not provide percentages. 
Results 
Population 
Nineteen countries were represented at the meeting, of which 18 completed the survey. One country 
was invited after the survey following a late cancellation and did not complete the survey. Seven 
organizations were represented, of which four were international, three were not restricted to nursing but 
had interprofessional membership, and five completed the survey, with two completing the survey from a 
country perspective. Five men were among the respondents. All delegates were fluent in English. 
Country delegates were predominately nursing leaders within their country but did not always have 
genetics expertise, and most held academic positions. Delegates came from countries with populations (in 
thousands) ranging from 2,380 (Australia) to 319,929 (United States). The number of nurses and midwives 
per 1,000 population varied widely from 0.6 (Pakistan) to 17.8 (Switzerland; Table S1; WHO, 
2017b). 
Half the country delegates (9 of 18) reported that the main source of healthcare services was health 
insurance systems funded by the government, citizens, employers, or a combination of those entities. Of 
the remaining, 8 of 18 reported they had a government funded system of which 5 included additional user 
fees at the time of use. Only one country, Pakistan, reported a decentralized, private system. Country-
specific gross domestic product spending on health care was as low as 3% (Pakistan) to as high as 17% 
(United States; WHO, 2017c; see Table S1). 
Nursing Qualifications to Practice 
Most countries reported that the qualification most nurses obtain to practice is a bachelor’s degree (9 of 
18) or associate degree (4 of 18), with fewer reporting obtaining a diploma (3 of 18) or certificates (2 of 
18). Despite this variation in qualification, most countries reported that entry-level training was 3 or 4 years 
(16 of 18), with 2 of 18 countries reporting 5 years. Most indicated that training occurred in universities or 
colleges (13 of 18). While hospital-based training was still prominent in three countries, one reported 
tertiary institutes, and one was transitioning from hospital- to university-based training. Five countries 
required examination such as a licensure or registration examination to practice. Four countries indicated 
there was no statutory regulatory body responsible for maintaining a nursing register and setting standards 
for education and practice. One country reported they do not have a national professional organization to 
represent nurses’ interests. 
Required Genomic Training for Nurses 
Only one country, Israel, indicated a requirement for all nurses to reach an agreed standard of knowledge 
and skills in genetics/genomics to practice, via a mandatory 28-hour course. Otherwise, the integration of 
genomics into nurse training was ad hoc and varied widely based on the country, with some countries 
reporting no genetic or genomic content included in training. Three countries indicated existence of 
genetic/genomic competencies applicable to all nurses regardless of clinical role, level of training, or 
specialty: Japan (Arimori et al., 2007); United Kingdom (Kirk, Tonkin, & Skirton, 2014); United States 
(Consensus Panel on Genetic/Genomic Nursing Competencies 2009; Greco, Tinley, & Seibert, 2012). 
Building on U.K. work, interprofessional competencies are available for European countries for primary, 
secondary, and tertiary (defined as genetic specialist) care (Skirton, Lewis, Kent, & Coviello, 2010). Only 6 
of 18 countries reported visible leadership driving developments in nursing to incorporate genomics. 
Specialist in Genomics 
All 18 countries reported the existence of a specialist genetics service, often in centers of excellence and 
consisting of genetic testing and counseling provided by trained or accredited individuals whose positions 
varied by country but included physicians, genetic counselors, and some nurses. Only 5 of 18 indicated 
there was a recognized specialist genetics nursing role (nurses with specialized training in genetics). Of 
those countries, four indicated they had agreed standards for specialist genetics nurses. A few countries 
reported that some genetic counselors are also nurses. 
Availability of Genomic Services 
The scope of genomic services offered globally varied (Table S2). The most widely available genetic 
services consist of newborn screening (15 of 18) and prenatal screening (11 of 18), though not prenatal 
testing (5 of 17). Genomic services were mostly offered in specialized centers only. Some countries 
reported not having one or more of the following genomic services: risk assessment and genetic testing for 
disease susceptibility; tumor sequencing; targeted therapies; or sequencing of infectious agents. One 
country reported the only genomic service was newborn screening. Only a few countries reported that 
genomics of common disease services, when offered, were widely available outside a specialty center: 
disease screening (2 of 16), disease prognosis (1 of 16), pharmacogenomics (2 of 14), and sequencing for 
infectious agents (5 of 15). 
The nursing roles delivering genomic services were a mixture within and between countries of specialist 
genetic nurse, specialist nurse, and advanced practice nurse (data not shown). Newborn screening, 
systematic family history taking, and prenatal screening were interventions where “any nurse” was most 
likely to be involved (eight, six, and five countries, respectively). 
Key Challenges 
Several potential challenges to clinical practice and nurse education were considered by both 
organizationand country-specific delegates. The most significant challenges or barriers to genomic 
integration into clinical practice consisted of (a) limited access to point of care educational information and 
clinical decision support; (b) lack of genomic expertise with limited training opportunities; (c) access to 
critical resources for training; and (d) resources that could link genetic variation to clinical implications (see 
Table S3a for specific data). High cost or lack of reimbursement and the need for resources to link genetic 
variation to clinical implications also ranked as significant challenges or barriers. Confusion over consent 
and privacy issues were considered as only a minimal challenge or barrier. 
Delegates identified a need for a cultural shift in the role of nurses in genomics. Comments included the 
need for development of clear career pathways in genomics for the registered nurse and the wider nursing 
workforce. Recommendations focused on demonstrating the relevance to nursing leaders such as directors 
of nursing and those responsible for setting standards. 
Education key challenges and barriers identified as the most significant included (a) insufficient 
curriculum time to cover genomics, (b) insufficient numbers of educators able to teach genomics, and (c) 
absence of required genomic competency assessments to practice nursing (see Table S3b for specific data). 
The absence of standards for genomic nursing education was viewed as significant by 12 countries as well 
as by ISONG, HEE, and ICN. Reluctance to consider different approaches to nurse training that facilitate 
integration of new knowledge and clinical advances, and the absence of national leadership in driving 
nursing genomics integration, were also important. Establishing relevance for nursing leaders involved in 
setting curricula was deemed critical as otherwise there is no incentive to prepare practitioners. 
More than three fourths of the countries (14 of 18) reported other significant or major competing 
priorities, including financial and political uncertainty. The absence of national leadership driving genomics 
integration into nursing was considered a significant issue. 
Policy Initiatives 
Country-specific policy initiatives have largely surrounded investments in large-scale genomic biomedical 
research. These include National Call for Research into Preparing Australia for the Genomics Revolution in 
Health Care; Brazil’s National Institutes of Science and Technology and its creation of the Family Cancer 
Network and Institute of Oncogenomica; China Kadoorieˆ Biobank; Japan’s Genomic Medical Realization 
Promotion Council; the U.K. 100,000 Genome Project; and the U.S. Precision Medicine Initiative, now 
renamed the All of Us Research Program. Initiatives have also focused on specific health issues or ethical 
and regulatory considerations, such as Pakistan’s Punjab Thalassemia Prevention Program; Germany’s 
Genetics Diagnostics Law; Switzerland’s National Criteria for Centers of Excellence in Rare Diseases; 
Taiwan’s recommendations for prenatal and newborn screening; the German Ethics Council’s position on 
genetic diagnosis; Turkey’s regulation of Genetic Disease Diagnosis Centers; and the U.K. Rare Disease 
Strategy. However, only 10 of 18 reported these national initiatives acknowledge the implications for 
nurses. Fewer still include genomic training for nursing and other healthcare professions, although the 
United Kingdom’s Genomics Education Programme is one exemplar (HEE, 2017). 
Priority Areas for Action 
The top three priority areas for action included raising awareness (22 of 22); education (21 of 22); and 
resources to support genomics in nursing (20 of 22). The creation of national and international 
collaborations also ranked highly. High priority areas identified in the survey included efforts to improve 
the status and visibility of nurses and nursing, generally and in relation to role in genomics as well as to 
facilitate the organization and delivery of genomic healthcare. 
Discussion 
To the best of our knowledge, this study represents the first landscape analysis of genomic healthcare 
services and nursing (education and practice) across multiple countries. Our aim was to conduct a 
landscape analysis that assessed the nursing and genomic trends in genomic literacy, clinical practice 
integration, and country-specific context inclusive of challenges and barriers. The current landscape 
revealed many global commonalities. National genomic sequencing initiatives are being implemented 
across the globe, and yet despite this, the largest single healthcare professional group, nurses, do not yet 
have genomics fully integrated into their practice, education, and policy. Genomic nursing literacy globally 
appears to be low given only one country requires genomic training, which is narrow in scope. 
Improvement may be limited, since the three primary education challenges were insufficient curriculum 
time for genomics, insufficient educators capable to teach genomics, and the absence of required genomic 
competency assessments to practice nursing. This contributes to limited genomic translation into practice, 
with most available services restricted to specialty clinics and not integrated into the general healthcare 
environment. Understanding this context informs priorities for action and identification of key strategies 
to influence change, including engagement and education of nursing practice and education leadership, an 
approach that may be useful for invigorating and sustaining any initiative (Calzone, Jenkins, Culp, & Badzek, 
in press). All of this can be greatly facilitated by global collaboration, the potential to learn from countries 
further along, and the sharing of expertise and resources to minimize duplication of effort. 
Unsurprisingly, the availability and complexity of genomic-based health services varies between 
countries, with a range of nursing roles involved in their delivery. Most services are located within 
specialized centers, with more established activities like prenatal and newborn screening, available for 
many years, being more widely available and being delivered by the nonspecialist nurse. We anticipate that 
the transition from specialized center to services that are more widely available will occur over time as 
technology becomes increasingly accessible and genomics becomes embedded within mainstream 
healthcare practice. However, it is important to be realistic about the scale of the challenge and what this 
entails. Davies (2017) remarked on the need to reform professional attitudes towards genomics and for a 
new genomic paradigm to be integrated into all training curricula for all clinicians. According to Davies, 
adopting genomic technologies requires changes in the design, operation, and workforce of healthcare 
organizations and raises concerns about the international shortage of skills and expertise. Davies’ 
comments highlight the importance of education, leadership, and willingness to change, the need for 
appropriate infrastructure, and the value of pooling international expertise. 
The education challenges presented here resonate with those identified in the literature. The 
engagement of nursing leadership is vital to establishing genomics competency as a workforce priority 
(Calzone et al., in press; Jenkins et al., 2015; Leach, Tonkin, Lancastle, & Kirk, 2016). To achieve 
engagement, relevancy of genomics must be established, which requires that nursing leaders attain 
competency in genomics sufficient to inform their decisions on competency standards and infrastructure 
priorities, such as point of care decision supports (Jenkins et al., 2015). Targeting nursing leadership is 
challenging as nursing leaders often view genomics as a niche specialty (Jenkins et al., 2015), but genomics 
represents a healthcare quality, safety, and cost issue in which larger policy mandates are needed to 
prioritize training in genomics for the practicing workforce (Calzone et al., in press). This is challenging given 
that most genomic initiatives globally focus on evidence generation, with limited attention paid to 
expanding the capacity of the existing healthcare workforce or the infrastructure necessary for effective 
translation of discoveries into practice. However, with the right government attitudes and investment, such 
as the U.K. 100,000 Genomes Project, evidence generation can be linked with increasing health 
professional capacity (HEE, 2017). Hoping that the solution will lie in the future nursing workforce is not 
realistic. The data from this landscape analysis document common global challenges that are well described 
in the literature, including lack of faculty capacity to teach genomics, a packed curriculum, and the absence 
of genomic educational standards (Jenkins & Calzone, 2014; Read & Ward, 2016). Addressing these deficits 
is hindered by the absence of regulatory bodies globally mandating some form of genomic nursing 
competency assessment. 
The trajectories of genomic translation (outlined above) in both nursing practice (from specialized to 
widely available) and nurse education lend themselves to measurement. A tool that can capture country-
specific and, in turn, global progress in integrating genomics into practice could be of great use to prioritize 
G2NA ongoing efforts and assess effectiveness. 
Genomics epitomizes a complex competency. The global workforce has little underpinning in the science 
of genomics, limiting capacity to understand the relevancy and even the literature given some of the 
terminology used. Many of the health or disease outcomes achieved by using genomics are not readily 
observable in terms of health or disease outcomes and can also consist of psychosocial outcomes, such as 
the value of knowing (Garrison, Mestre-Ferrandiz, & Zamora, 2016). For example, identifying an individual 
with a genetic predisposition to a disease such as cancer provides an opportunity to implement strategies 
aimed at risk reduction or early detection. Utilizing a pharmacogenomic test to inform treatment options 
may help alleviate adverse drug events and improve efficacy, superior to the trial and error approach most 
often utilized (Ciardiello et al., 2014). 
Rogers’ Diffusion of Innovations (2003) documents that this complexity and lack of observability all slow 
adoption. Policy approaches, the involvement of critical healthcare leaders, and the utilization of opinion 
leaders, such as the G2NA delegates, can help facilitate adoption (Leach et al., 2016). But those G2NA 
country delegates alone will not be sufficient. The contribution of critical nursing organizations such as the 
ICN and STTI, which have considerable respect and position in the global healthcare arena, are positioned 
to influence nursing leaders and policy internationally, and were specifically targeted for participation in 
this effort. Genomics integration into practice is absolutely an interprofessional issue (Passamani, 2013). 
Nursing, through global collaboration and interface with critical nursing leaders, can be a catalyst for all 
health professions to achieve the capacity to integrate genomics into practice and education to realize the 
healthcare benefits. 
The findings from our landscape analysis underpin the future work of the G2NA. This alliance is not 
targeting the genetic specialist, but is aimed at genomic integration in everyday nursing practice and 
education though the sharing of resources, expertise, and mobilization of organizations that can help 
influence nursing leaders and policy directions. 
Limitations 
These findings have some limitations that need to be considered. The instrument used to collect the data 
was developed by the project leadership team. Apart from content validity using expert reviewers, the 
instrument was not otherwise tested for construct validity and reliability as that was not appropriate given 
the very narrow target audience for this survey. 
Given funding constraints, not all countries and international nursing organizations were represented, 
though the G2NA provides a platform for growth in this arena. Furthermore, the data are based on the 
knowledge and views of just one individual from each country or organization. This project utilized a 
purposive sampling strategy. While the authors attempted to identify people optimally positioned to 
address the state of nursing in their country or organization, a single individual may not have the full details 
associated with every survey item. There are very few high-level nurse leaders globally who can comment 
on the state of nursing practice in their country; thus, the numbers we could involve are limited. We do not 
claim that those involved were representative in any way of the entire nurse leader population. 
Given these limitations, our findings may not accurately reflect the global state of nursing and genomics. 
Therefore, these findings should be considered as one initial snapshot of a potential state of nursing in 
genomics that will inform the next steps in establishing the G2NA to facilitate and accelerate the integration 
of genomics into nursing practice. 
Conclusions 
The findings from this landscape analysis provide a foundation to inform the development of strategies 
to address common challenges and prioritize collaborative activities to accelerate the integration of 
genomics into nursing. The findings also support the concept of global commonalities of pathways to 
genomic adoption amenable to the development of a tool to guide and track progress. Now more than 
ever before, nursing exists in a global environment. By working together, we can mobilize information, 
resources, and strategies to realize the benefits of genomics for the patients that we serve. 
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 Genetic and Genomic Competency Center for Education: http://genomicseducation.net/ 
 Health Education England. Genomics Education Programme: https://www.genomicseducation.hee. 
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